Sorescu Teodora, Cosnita Andrei, Braha Adina, Timar Romulus, Timar Bogdan, Licker Monica, Lazar Sandra, Gaita Laura, Albai Oana, Popescu Simona
Second Department of Internal Medicine: Diabetes, Nutrition, Metabolic Diseases, and Systemic Rheumatology, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Department of Diabetes, Nutrition and Metabolic Diseases, "Pius Brînzeu" Emergency Clinical County Hospital, 300723 Timisoara, Romania.
J Clin Med. 2024 Dec 14;13(24):7628. doi: 10.3390/jcm13247628.
Patients with diabetes (DM) are at an increased risk of infection, with urinary tract infections (UTIs) being common among individuals with type 2 DM (T2D). The aim of this study was to determine the prevalence and risk factors for UTIs among hospitalized T2D patients from Timișoara, Romania. The hospital records of 1139 T2D adult inpatients who were ordered to provide urine cultures during hospitalization were reviewed. The prevalence of UTIs among T2D patients was 19.7%, and was higher in women than in men (27.5% vs. 9.8%, < 0.0001). Patients with UTIs presented a significantly older age, a longer duration of DM, a higher BMI, higher levels of HbA1c, higher renal function parameters, and more frequent DM-related complications and comorbidities than patients without UTIs. The following predictors were associated with increased UTI risk: age (OR = 1.05, < 0.0001); duration of DM (OR = 1.04, < 0.0001); BMI (OR = 1.05, < 0.0002); HbA1c levels (OR = 1.58, < 0.0001); female gender (OR = 3.47, < 0.0001); and the presence of retinopathy (OR = 1.47, = 0.0118), chronic kidney disease (OR = 3.98, < 0.0001), distal symmetric polyneuropathy (OR = 7.65, < 0.0001), and cerebrovascular disease (OR = 4.88, < 0.0001). The use of sodium-glucose co-transporter 2 (SGLT2) inhibitors did not influence the risk of developing UTIs. T2D patients with prolonged disease duration, poor glycemic control, and DM-related complications are at an increased risk of developing UTIs. Therefore, a targeted therapeutic strategy addressing these risk factors is essential.
糖尿病(DM)患者感染风险增加,尿路感染(UTIs)在2型糖尿病(T2D)患者中很常见。本研究的目的是确定罗马尼亚蒂米什瓦拉住院T2D患者中UTIs的患病率和危险因素。回顾了1139例住院期间被要求进行尿培养的T2D成年住院患者的医院记录。T2D患者中UTIs的患病率为19.7%,女性高于男性(27.5%对9.8%,<0.0001)。与无UTIs的患者相比,UTIs患者的年龄显著更大、DM病程更长、BMI更高、HbA1c水平更高、肾功能参数更高,且DM相关并发症和合并症更频繁。以下预测因素与UTI风险增加相关:年龄(OR = 1.05,<0.0001);DM病程(OR = 1.04,<0.0001);BMI(OR = 1.05,<0.0002);HbA1c水平(OR = 1.58,<0.0001);女性(OR = 3.47,<0.0001);以及视网膜病变(OR = 1.47,= 0.0118)、慢性肾病(OR = 3.98,<0.0001)、远端对称性多发性神经病变(OR = 7.65,<0.0001)和脑血管疾病(OR = 4.88,<0.0001)的存在。使用钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂不会影响发生UTIs的风险。病程延长、血糖控制不佳和DM相关并发症的T2D患者发生UTIs的风险增加。因此,针对这些危险因素的靶向治疗策略至关重要。